Low back pain represents a significant social and economic burden, including direct medical costs, lost production, and disability benefits, and lowers the quality of life of many individuals.
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1,2 Low back pain is strongly associated with the intervertebral disk (IVD) degeneration, and IVD degeneration is also associated with sciatica and disk herniation or prolapse. It possibly adversely affects the behavior of other spinal structures such as muscles and ligaments. In the long term it can lead to spinal stenosis, a major cause of pain and disability in the elderly. Therefore, it follows that the suppression of IVD degeneration may limit the pain and disability associated with a range of pathologies of the back. Accordingly, clarification of the pathophysiology of IVD degeneration and its associated pain currently represents a major biomedical research priority. Much research is going on to understand IVD at a molecular level in hopes of creating clinically applicable options for treating IVD degeneration. Despite extensive study of the degenerative process in the IVD, the exact mechanism of diskogenic low back pain (IVD-related pain) has not been elucidated. In this review, we describe recent studies on diskogenic low back pain that have shed new light on the molecular mechanism and intracellular signaling pathways involved.
Disk Morphology
The IVD lies between the vertebral bodies, separated from them by the end plate and consisting of two main regions: an inner, soft and highly hydrated structure, the nucleus pulposus, and an outer, annulus fibrosus. Their major role is mechanical functions, as they constantly transmit loads arising from body weight and muscle activity through the spinal column. In addition, the IVD is the largest avascular tissue in the body, and the essential nutrients are supplied to the disk virtually entirely by diffusion.
3 Some groups have reported that several intrinsic and extrinsic factors influence
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Abstract
Many of the causes of low back pain are still unknown; sufficient evidence indicates that both degenerative and mechanical change within the intervertebral disk (IVD) is a relevant factor. This article reviews intracellular signaling pathways related to pain receptors in the degenerated IVD. Several reports have demonstrated the number of nerve fibers in the IVD was increased in degenerated disks. In recent years, some groups have reported that an increase in nerve fibers is associated with the presence of inflammatory mediators and/or neurotrophins in the IVD. Cell signaling events, which are regulated by inflammatory mediators and neurotrophins, must be identified to clarify the mechanism underlying low back pain. Major intracellular signaling pathways (nuclear factor kappa β, mitogen-activated protein kinases, and Wnts) potentially play vital roles in mediating the molecular events responsible for the initiation and progression of IVD degeneration. These signaling pathways may represent therapeutic targets for the treatment of IVD degeneration and its associated back pain.
the cellular and molecular state of the IVD, including aging, genetics, transport of nutrients, and the mechanical environment.
4-7 This makes it difficult to distinguish the vital cell type to target for therapeutic measures. Despite this complexity, recent studies have shown that there are considerable interspecies variations in the phenotypical characteristics of the cells. Although phenotypical similarities and characteristics exist between nucleus pulposus cells and articular chondrocytes, distinct differences have been identified.
8,9
Nucleus pulposus cells of the IVD, which had generally been referred to as "chondrocyte-like" or "notochordal" cells, have been profiled and characterized in detail. The cells of the mature human nucleus pulposus are primarily chondrocytelike cells, but in young individuals and in adults of some species, there is a second population of large cells with cytoplasmic inclusions. These are the "notochordal cells." The notochordal cells express type IIA collagen, the differentially spliced form of type II collagen typical of prechondrocytes, rather than the alternate type IIB collagen, which is expressed by mature chondrocytes; they also express small proteoglycans mRNAs such as versican and decorin, more characteristic of fibroblast. These characteristics are of crucial importance for the success of regenerative and repair strategies, considering the structural and mechanical distinctions between IVD and cartilage tissues.
Effect of Degenerative Changes on Intervertebral Disk Cell Signaling
Major Intracellular Signaling Pathways for IVD Degeneration
With increasing age and degeneration, the most significant biochemical change to occur in IVD degeneration is loss of proteoglycans. These proteoglycans enable the nucleus pulposus to retain water, thereby cushioning and absorbing the considerable loads placed on the tissue. With increasing age and degeneration, the nucleus pulposus eventually becomes more fibrous tissue, and the peripheral anulus fibrosus is forced to carry larger loads, leading to tears, bulging, rupture, and herniation. In addition, loss of proteoglycans in degenerate disks influences the movement of molecules into and out of the IVD. Specifically, loss of aggrecan and type II collagen would allow increased penetration of large molecules such as growth factor complexes and cytokines into the IVD, affecting cellular behavior and possibly the progression of degeneration (►Fig. 1). Therapeutic strategies for the biological treatment of IVD degeneration include the use of cellular components (mesenchymal stem cells, chondrocytes, and culture-expanded nucleus pulposus cells), matrix derivatives, molecules influencing disk-cell metabolism, and tissue-engineering strategies to restore function to the IVD degeneration.
10-14
Focusing on molecular therapy, some groups have reported that the biochemistry of IVD degeneration is commonly attributed to the dual effects of increased catabolic factors, such as matrix metalloproteinases (MMPs) and interleukin (IL)-1, and decreased anabolic factors such as transforming growth factors (TGFs) and bone morphogenetic proteins (BMPs). The balance between synthesis and breakdown of matrix macromolecules by the intracellular signaling pathways determines the quality and integrity of the matrix, and thus the mechanical behavior of the IVD. 
45-47
MAPK signaling research in the IVD has shown that the p38 and extracellular signal-regulated kinase (ERK) signaling pathways play a significant role in extracellular metabolism, because treatment with targeted kinase inhibitors significantly counteracted cytokine-induced changes in proteoglycan content, synthesis, and release.
20, 48 In addition, several signaling intermediates and factors of the MAPK pathway have been identified in IVD cells. 49, 50 Some groups have reported that TGF, nerve growth factor (NGF), platelet-derived growth factor, insulin-like growth factor-I, and basic fibroblast growth factor, all known to be overexpressed in In addition, fibroblast growth factor-2 (FGF-2) has been identified as an anabolic mediator of disk homeostasis, an effect that may result from FGF-2-mediated stimulation of proteoglycan synthesis, such as seen in a canine IVD tissue culture system, or upregulation of cell proliferation such as seen in rat disks. 57, 58 In contrast, the findings of Li et al and
Peng et al suggest that FGF-2 primarily has a catabolic role in disk homeostasis. 59, 60 Based on these apparently conflicting findings, it seems likely that FGF-2 plays multiple roles in disk homeostasis, and also that this may change depending on the stage of degeneration and the nature of the disease process. Against the background of these intracellular signaling pathways, cell or growth factor therapies have recently been suggested to induce IVD repair in these signals and/or factors as target. However, one problem with the use of growth factors and/or cytokines in clinical trials is their high cost and safety. For these concern, Mwale et al have reported that Link N (DHLSDNYTLDHDRAIH) can stimulate the synthesis of aggrecan and collagen in the bovine IVD cells in vitro, 61, 62 as well as in the IVDs of rabbits in vivo. 63 The changes in proteoglycan synthesis with Link N are similar to those reported previously with the same concentration of osteogenic protein-1 (OP-1). Link N agent can be treated with the low cost than OP-1 for the IVD degeneration. Link N therefore represents a potential economical therapeutic agent with beneficial effects. Their group has reported that Link N is also able to downregulate MMP expression in the degenerate IVDs, enhance the chondrogenic differentiation, and downregulate hypertrophic and osteogenic differentiation of human MSCs.
64

Roll of Wnt Signaling in IVD Cells
In recent years, it has been also reported that Wnt signaling may play a crucial role of the cellular responses that lead to IVD inflammation and catabolism, much as they are involved in bone and cartilage metabolism. Wnts are secretory proteins of 40 kDa that control multiple aspects of development, including the proliferation, fate specification, polarity, and migration of cells. 65, 66 In addition, Chou et al reported that Wnt-1 and Wnt-3a both inhibit NGF-induced neurite outgrowth from PC12 cells. 67 These results showed that sensory nerve receptors and neurotrophic markers cooperate with Wnt signals in regulating many biological processes, but the mechanisms of their interaction remain poorly defined in the IVD. Wnt signaling can occur via the canonical Wnt/β-catenindependent pathway (hereafter called Wnt) or the noncanonical β-catenin-independent pathway, which itself can be divided into the planar cell polarity pathway and the Wnt/ Ca 2þ pathway. 68 Among these, the canonical pathway is the most well characterized. Wnt proteins are glycoproteins that bind to the N-terminal extracellular cysteine-rich domain of the Frizzled (Fz) receptor family, of which there are 10 variants in humans. Fz is a seven-transmembrane-span protein with topological homology to G-protein-coupled receptors. In addition to the interaction between Wnt and Fz, coreceptors are also required for mediating the Wnt signaling. For example, the low-density-lipoprotein-related protein 6 is required to mediate Wnt signaling via the canonical pathway. On activation of this pathway, the cytoplasmic β-catenin is translocated to the nucleus, where it promotes binding of the transcription factor, T-cell factor/lymphocyte-enhancing factor, thereby accelerating the expression of target genes.
69-71
It is well known that Wnt signaling plays a major role in bone metabolism. It has been shown that although the Wnt signaling suppresses differentiation of mesenchymal stem cells into chondrocytes and adipocytes, it accelerates their differentiation into osteoblasts and osteocytes. Following activation of the Wnt signaling, osteoprotegerin, which is a decoy for the receptor activator of NF-κβ ligand, is generated from osteoblasts, and ossification is accelerated as a result of inhibiting the activation of osteoclasts. Moreover, cross talk between Wnt signaling and other pathways that regulate ossification, such as the BMP pathway, is also known. 72, 73 In cartilage metabolism, it has been suggested that β-catenin is involved in the modulation of both anabolic and catabolic activities, suggesting that Wnt signaling also modulates inflammatory cytokine expression. [74] [75] [76] Furthermore, it also appears that the activation of Wnt signaling may cause cellular senescence and thereby contribute to the process of IVD degeneration.
77
Hiyama et al reported that rat nucleus pulposus cells undergo aging when treated with LiCl, consistent with the fact that LiCl is an activator of Wnt signaling that suppresses cell proliferation. 78 Moreover, it has been reported that the activation of Wnt signaling in the IVD induces other pathways, including the TGF/BMP pathway, and that it is the cross talk between these pathways that ultimately controls the turnover of the extracellular matrix. In addition, they demonstrated both the expression of notochord-specific genes and the size of the notochord decline in the absence of Wnt signaling, and this is probably because Wnt signaling is essential for stabilization of the NPC phenotype. 81 Wang et al also investigated the gene expression of catabolic factors with β-catenin conditional (cAct) mice and found that the expression of both MMP13 and ADAMTS-5 was increased in the IVDs of β-catenin knockouts, consistent with the observed IVD degeneration. Moreover, they found that IVD degeneration was suppressed when an inhibitor of MMP13 was administered to β-catenin cAct mice. From these results, it was concluded that β-catenin is a key factor responsible for the maintenance of the IVD tissue structure.
To date, although there are a lot of studies of the intracellular signaling pathways in IVD, we should keep in mind that the final effect of the activation of signaling depends on their "signaling cross talk" with other activated signaling pathways. Therefore, it is necessary to investigate the importance of elucidating the cellular mechanisms of IVD degeneration and to build map of intracellular signaling pathways in IVD.
Pain and Innervations for the IVD
The normal IVD is considered to be a poorly innervated organ that is supplied only by sensory and sympathetic perivascular nerve fibers. Furthermore, there is widespread agreement that an important priority is to identify factors sensitizing the sensory nerves of the degenerated IVD. Regarding the neuropathology of IVDs studied in Japan, the analysis performed on surgical samples in 1970 by Shinohara was the first to describe a novel nerve terminal in the process of invading the annulus fibrosus. 87 Burke et al have compared the levels of L-6, IL-8, and prostaglandin E 2 in disk tissue from patients undergoing diskectomy for sciatica (n ¼ 63) with that from patients undergoing fusion for diskogenic low back pain (n ¼ 20). They suggested that the presence of inflammatory mediators IL-6 and IL-8 in the IVD might be involved in axonal ingrowth. 88 Le Maitre et al demonstrated that herniated disks and degenerated disks from patients with chronic back pain showed a higher expression of IL-1β and TNF-α than nondegenerated disks derived from normal postmortem tissue.
89
Weiler et al also demonstrated that surgical disk tissue from symptomatic back pain patients contained more TNF-α-positive cells than asymptomatic autopsy samples, with a positive correlation to the degree of IVD degeneration. 90 These findings suggest that inflammation promotes the growth of afferent fibers in the disk and that this growth might be the cause of low back pain. To elucidate the cause of diskogenic low back pain, we also think that these points are very important. Furthermore, the predominant nerve cells of the IVD have been characterized in recent years using activating transcription factor 3 (ATF3) as a marker of nerve injuries and GAP43 as a marker of axonal growth. In one study, Inoue et al characterized nerve cells in a rat model of IVD disease by creating a punch hole connecting the outside of the annulus fibrosus and the nucleus pulposus. They concluded that the procedure induced nerve injury and resulted in nerve ingrowth into the disks. 91 A role for NGF in the ingrowth was indicated by subsequent studies showing enhanced levels in degenerated IVDs. Indeed, the study of neural and neurotrophic markers has been a very active area of IVD research in recent years. [92] [93] [94] [95] [96] For example, neurotrophins have been shown to enhance the survival and differentiation of discrete populations of peripheral nerve neurons. The neurotrophins NGF and brain-derived neurotrophic factor (BDNF), which are associated with stimulation of axonal outgrowth and nociception by neuronal cells, are both expressed by nucleus pulposus cells, with BDNF levels increasing with disease severity. Meanwhile, the pain transmitters in the sensory nerves dominating the IVDs have also been characterized, and it has been shown that neuropeptides such as substance-P and calcitonin gene-related peptide are expressed in the outer layer of the annulus fibrosus. 97 In addition, sensory nerve receptors such as NGF receptors, tyrosine kinase A, p75 neurotrophin receptor, and transient receptor potential V1 are present in IVDs. 98 Moreover, degenerative conditions have been shown to induce the expression of receptor ligands and could modify the perception of pain. Regarding modulation of the afferent pathway of IVDrelated low back pain, it is generally accepted that nerve excitation is enhanced by inflammation of the nerves and by mechanical stress. In terms of the specific afferent pathways involved, in 1993 Takahashi et al reported that the L5-6 IVD in the rat is innervated bilaterally from the L1 and L2 dorsal root ganglia through the paravertebral sympathetic trunk.
99
The authors found that injection of capsaicin, a C-fiber stimulator, into the anterior portion of a lumbar IVD of rats pretreated intravenously with Evans blue caused dye extravasation of the pigment in the groin skin. Evans Blue is an azo dye which has a very high affinity for serum albumin. Vascular permeability was assessed by measuring Evans blue dye extravasation. These results suggested the presence of dichotomizing sensory C-fibers, which innervate both the IVDs and the groin skin in the L2 spinal nerve. 99 Subsequently, to elucidate the afferent pathways of diskogenic low back pain in humans, Nakamura et al hypothesized that low back pain was transmitted mainly by sympathetic afferent fibers in the L2 nerve root, and selective local anesthesia of this nerve was employed in 33 patients. Low back pain disappeared or decreased significantly in all patients after the injection. under the control of both the paravertebral sympathetic trunks and the sinuvertebral nerves. 15,101 Moreover, Kurokawa et al employed double fluorescent labeling using two types of neurotracers, 1,1-dioctadecyl-3,3,3,3-tetramethylindocarbocyanine perchlorate and FG, in rat lumbar disks and reported that one sensory nerve was innervating lumbar disks at multiple levels.
16
From these basic research results, it is believed that when IVD degeneration occurs, such as inflammation within the annulus fibrosus and/or herniation of the nucleus pulposus, nerves with mainly C-fibers germinate from the annulus fibrosus inward, thereby causing neurogenic inflammation and leading to aggravation of pain.
Accordingly, clarifying the pathophysiologic mechanism by which IVD degeneration occurs will be required for any improvement in the current treatments for diskogenic low back pain.
Summary
Low back pain is attributed to several medical disorders including lumbar herniation, scoliosis, and muscle and ligament damage, although most importantly, IVD degeneration is associated with up to 40% of individuals under 30 years of age.
102
In recent years, attention has begun to focus on the cellular and molecular mechanism and signaling of IVD in the search for an understanding of the pathophysiology of low back pain (►Fig. 2). In terms of molecular alterations, the balance between matrix anabolism and catabolism that exists in the nondegenerate IVD is shifted toward catabolism in degeneration, due to the production of matrix-degrading enzymes MMPs and ADAMTSs by MAPK and/or NF-κβ pathways, among others. The most significant molecular alteration is thought to be the upregulated expression of inflammatory cytokines and/or neurotrophins. In addition, it was demonstrated recently that Wnt signaling is a key pathway to regulate and maintain the IVD homeostasis. However, degeneration of the IVD is an incredibly complex disorder; moreover, many of the results implicating molecular signaling were obtained with cells and tissues from rodent models. Therefore, much research is needed to gain a better understanding of these signals and how their "cross talk" with other pathways will be likely to influence the outcome of treatments for IVD degeneration in vivo. Recent studies have demonstrated the presence of cell niches and progenitor cells in the IVD.
103, 104 Kim et al have reported that end plate chondrocytes of the IVD, like articular chondrocytes, are capable of migration and that soluble factors produced by notochordal cells stimulate the migration. 105 The identification of progenitor cells within IVD indicates that natural repair mechanisms exist within the IVD and may be activated for regeneration, although the signal mechanisms and function of these cells need to be elucidated. Sakai et al also showed for the first time an experimental model of nucleus pulposus differentiation induced from functional progenitor cells in vivo. They suggested that Tie2 is a sensitive marker of aging and degeneration of IVDs and will be a useful marker for the diagnosis of IVD degeneration. 106 Future studies are needed to examine whether progenitor cells can be used to inhibit nerve ingrowth or nociceptor formation in degenerate IVDs. Novel biological strategies will be more successful to treat and prevent disk degeneration and finally contribute to treatment of the low back pain if the specific disk cell phenotypes, functions, and molecular signaling are taken into consideration. 
